US Broker Ratings

Amedisys Inc (AMED) Stock Analysis: Insights into Its Healthcare Growth and Analyst Ratings

Amedisys Inc (NASDAQ: AMED), a notable player in the healthcare sector, is carving out a significant niche within the medical care facilities industry. With a market..

Beam Therapeutics Inc. (BEAM) Stock Analysis: Unveiling a 130% Potential Upside in the Biotech Arena

Beam Therapeutics Inc. (NASDAQ: BEAM) is capturing the attention of investors with its promise of a significant potential upside, despite facing challenging financial metrics. Specializing in..

Ocular Therapeutix, Inc. (OCUL) Stock Analysis: A 37% Potential Upside Amid Biotech Innovation

Ocular Therapeutix, Inc. (NASDAQ: OCUL) is capturing investor attention with its innovative approach to treating ocular diseases and its potential upside of 37.33%. The company, headquartered..

Arcutis Biotherapeutics, Inc. (ARQT) Stock Analysis: A Promising 26% Upside in the Biotech Arena

Arcutis Biotherapeutics, Inc. (NASDAQ: ARQT) has emerged as a notable contender in the biotechnology sector, focusing on innovative dermatological treatments. With a market cap of $2.08..

AdaptHealth Corp. (AHCO) Stock Analysis: Exploring a 39% Potential Upside

AdaptHealth Corp. (NASDAQ: AHCO) operates within the healthcare sector, specifically in the medical devices industry, and is becoming a noteworthy consideration for investors looking to capitalize..

Biohaven Ltd. (BHVN) Stock Analysis: Exploring a Potential 237% Upside in the Biotech Sector

Biohaven Ltd. (NASDAQ: BHVN), a notable player in the biotechnology sector, has captured investor attention with its ambitious pipeline and significant potential upside. With a market..

Twist Bioscience Corporation (TWST) Stock Analysis: Unveiling a 52.38% Potential Upside

Twist Bioscience Corporation (NASDAQ: TWST), a prominent player in the healthcare sector, is drawing attention with its promising outlook and robust growth potential. Operating in the..

Liquidia Corporation (LQDA) Stock Analysis: A Biotech with a 31% Potential Upside

Liquidia Corporation (NASDAQ: LQDA), a promising player in the biotechnology sector, has captured investor attention with an impressive potential upside of 31.05%. Specializing in innovative treatments..

Dyne Therapeutics, Inc. (DYN) Stock Analysis: Discovering a Potential 165% Upside in Biotech Innovation

Dyne Therapeutics, Inc. (NASDAQ: DYN) is making waves in the biotechnology sector with its innovative approach to treating neuromuscular diseases. As a clinical-stage company based in..

AtriCure, Inc. (ATRC) Stock Analysis: 38.89% Potential Upside with Strong Buy Ratings

AtriCure, Inc. (NASDAQ: ATRC) stands out as a compelling investment opportunity within the healthcare sector, specifically under the medical instruments and supplies industry. With innovative products..

Sotera Health Company (SHC) Stock Analysis: Navigating Growth in the Healthcare Sector with a 0.57% Potential Upside

Sotera Health Company (NASDAQ: SHC) stands as a formidable entity in the healthcare sector, specializing in diagnostics and research. Headquartered in Broadview Heights, Ohio, Sotera Health..

Xenon Pharmaceuticals (XENE) Stock Analysis: Exploring a 43.88% Upside Potential

In the dynamic world of biotechnology, Xenon Pharmaceuticals Inc. (NASDAQ: XENE) stands out as a compelling investment opportunity, particularly for those focused on the healthcare sector...

Immunovant, Inc. (IMVT) Stock Analysis: Exploring a 145% Potential Upside in the Biotech Sector

Immunovant, Inc. (NASDAQ: IMVT) is capturing the attention of investors with its substantial growth potential in the biotechnology sector. As a clinical-stage immunology company, Immunovant specializes..

Ligand Pharmaceuticals (LGND) Stock Analysis: A Biotech Player with 7.39% Upside Potential

Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) is a notable player in the biotechnology sector, offering a diverse portfolio of biopharmaceuticals that target a wide range of diseases...

IDEAYA Biosciences, Inc. (IDYA) Stock Analysis: Exploring a 99% Potential Upside in Precision Oncology

IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a pioneering force in precision medicine oncology, is capturing investor attention with a notable 99.34% potential upside, according to analyst ratings...

89bio, Inc. (ETNB) Stock Analysis: A 254% Upside Potential in the Biotech Sector

For investors with a penchant for the high-stakes world of biotechnology, 89bio, Inc. (NASDAQ: ETNB) presents an intriguing opportunity. This clinical-stage biopharmaceutical company, headquartered in San..

Veracyte, Inc. (VCYT) Stock Analysis: Exploring a 22.46% Potential Upside in Healthcare Diagnostics

Veracyte, Inc. (NASDAQ: VCYT), a pioneering player in the healthcare diagnostics sector, has captured investor attention with its innovative genomic testing solutions and a promising potential..

GeneDx Holdings Corp. (WGS) Stock Analysis: A Look at Its Impressive 45.6% Revenue Growth in the Health Sector

GeneDx Holdings Corp. (NASDAQ: WGS) is making waves in the healthcare sector with its robust focus on genetic testing services, particularly in pediatric and rare disease..

National HealthCare Corporation (NHC) Stock Analysis: A Solid Performer with a 28.7% Revenue Growth Potential

National HealthCare Corporation (NYSE: NHC), headquartered in Murfreesboro, Tennessee, is making waves in the healthcare sector with a remarkable 28.7% revenue growth. This performance metric stands..

Phreesia, Inc. (PHR) Stock Analysis: A 26.96% Upside Potential in the Health Information Services Sector

Phreesia, Inc. (NYSE: PHR), a prominent player in the health information services industry, offers investors an intriguing opportunity with a potential upside of 26.96%, according to..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds